Top

Published in:

01-03-2013 | Original Article

The incidence and prevalence of temporomandibular disorders and posterior open bite in patients receiving mandibular advancement device therapy for obstructive sleep apnea

Authors: Cristina V. Perez, Reny de Leeuw, Jeffrey P. Okeson, Charles R. Carlson, Hsin-Fang Li, Heather M. Bush, Donald A. Falace

Published in: Sleep and Breathing | Issue 1/2013

Abstract

Purpose

This study aims to evaluate the incidence and prevalence of temporomandibular disorders (TMD) in patients receiving a mandibular advancement device (MAD) to treat obstructive sleep apnea using the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). In addition, it also aims to assess the development of posterior open bite (POB).

Materials and methods

Data from 167 patients were evaluated at baseline, from 159 patients after 118 days (visit II), from 129 patients after 208 days (visit III), and from 85 patients after 413 days (visit IV). The presence of TMD symptoms was evaluated through a questionnaire. TMD signs were assessed using the RDC/TMD. Clinical evaluation assessed for the presence of POB.

Results

The prevalence of TMD was 33/167 (19.8 %) at baseline. After an initial decrease to 14.5 % on visit II, the prevalence increased to 19.4 % on visit III and finally demonstrated a decrease to 8.2 % on visit IV. The incidence of TMD was 10.6 % on visit II. This decreased on further visits and only two (1.9 %) patients developed TMD from visit III to visit IV. POB was found to develop with an average incidence of 6.1 % per visit. The prevalence of POB was 5.8 % on visit II, 9.4 % on visit III, and 17.9 % on visit IV.

Conclusion

The use of MADs may lead to the development of TMD in a small number of patients. Nevertheless, these signs are most likely transient. Patients with pre-existing signs and symptoms of TMD do not experience significant exacerbation of those signs and symptoms with MAD use. Furthermore, these may actually decrease over time. POB was found to develop in 17.9 % of patients; however, only 28.6 % of these patients were aware of any bite changes.

Yaggi HK, Strohl KP (2010) Adult obstructive sleep apnea/hypopnea syndrome: definitions, risk factors, and pathogenesis. Clin Chest Med 31(2):179–186PubMedCrossRef

Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163(1):19–25PubMed

Eskafi M, Ekberg E, Cline C, Israelsson B, Nilner M (2004) Use of a mandibular advancement device in patients with congestive heart failure and sleep apnoea. Gerodontology 21(2):100–107PubMedCrossRef

Sjostrom C, Lindberg E, Elmasry A, Hagg A, Svardsudd K, Janson C (2002) Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax 57(7):602–607PubMedCrossRef

Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, Ewy GA, Howard BV, Punjabi NM (2003) Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 26(3):702–709PubMedCrossRef

Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, Boehlecke B, Brown TM, Coleman J Jr, Friedman L, Kapen S, Kapur VK, Kramer M, Lee-Chiong T, Owens J, Pancer JP, Swick TJ, Wise MS (2006) Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 29(3):375–380PubMed

Engleman HM, Wild MR (2003) Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev 7(1):81–99PubMedCrossRef

Rogers RR (2000) Oral appliance therapy for the management of sleep disordered breathing: an overview. Sleep Breath 4(2):79–84PubMed

Kushida CA, Morgenthaler TI, Littner MR, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Owens J, Pancer JP (2006) Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep 29(2):240–243PubMed

10.

Tan YK, L'Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, Spiro SG, Battagel JM (2002) Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomized cross-over trial. Eur J Orthod 24(3):239–249PubMedCrossRef

11.

Walker-Engstrom ML, Ringqvist I, Vestling O, Wilhelmsson B, Tegelberg A (2003) A prospective randomized study comparing two different degrees of mandibular advancement with a dental appliance in treatment of severe obstructive sleep apnea. Sleep Breath 7(3):119–130PubMedCrossRef

12.

Marklund M, Sahlin C, Stenlund H, Persson M, Franklin KA (2001) Mandibular advancement device in patients with obstructive sleep apnea: long-term effects on apnea and sleep. Chest 120(1):162–169PubMedCrossRef

13.

Gotsopoulos H, Chen C, Qian J, Cistulli PA (2002) Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 166(5):743–748PubMedCrossRef

14.

Blanco J, Zamarron C, Abeleira Pazos MT, Lamela C, Suarez Quintanilla D (2005) Prospective evaluation of an oral appliance in the treatment of obstructive sleep apnea syndrome. Sleep Breath 9(1):20–25PubMedCrossRef

15.

Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W (2006) Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 29(2):244–262PubMed

16.

Yoshida K (2006) Effect on blood pressure of oral appliance therapy for sleep apnea syndrome. Int J Prosthodont 19(1):61–66PubMed

17.

Otsuka R, Ribeiro de Almeida F, Lowe AA, Linden W, Ryan F (2006) The effect of oral appliance therapy on blood pressure in patients with obstructive sleep apnea. Sleep Breath 10(1):29–36PubMedCrossRef

18.

Gotsopoulos H, Kelly JJ, Cistulli PA (2004) Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep 27(5):934–941PubMed

19.

Andren A, Sjoquist M, Tegelberg A (2009) Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance—a three-year follow-up. J Oral Rehabil 36(10):719–725PubMedCrossRef

20.

Jonsson T, Arnlaugsson S, Saemundsson SR, Magnusson TE (2009) Development of occlusal traits and dental arch space from adolescence to adulthood: a 25-year follow-up study of 245 untreated subjects. Am J Orthod Dentofacial Orthop 135(4):456–462PubMedCrossRef

21.

Almeida FR, Lowe AA, Sung JO, Tsuiki S, Otsuka R (2006) Long-term sequellae of oral appliance therapy in obstructive sleep apnea patients: part 1. Cephalometric analysis. Am J Orthod Dentofacial Orthop 129(2):195–204PubMedCrossRef

22.

Ueda H, Almeida FR, Lowe AA, Ruse ND (2008) Changes in occlusal contact area during oral appliance therapy assessed on study models. Angle Orthod 78(5):866–872PubMedCrossRef

23.

Dube C, Rompre PH, Manzini C, Guitard F, de Grandmont P, Lavigne GJ (2004) Quantitative polygraphic controlled study on efficacy and safety of oral splint devices in tooth-grinding subjects. J Dent Res 83(5):398–403PubMedCrossRef

24.

De Leeuw R, American Academy of Orofacial P (2008) Orofacial pain: guidelines for assessment, diagnosis, and management. Quintessence, Chicago

25.

Cunali PA, Almeida FR, Santos CD, Valdrighi NY, Nascimento LS, Dal'Fabbro C, Tufik S, Bittencourt LR (2009) Prevalence of temporomandibular disorders in obstructive sleep apnea patients referred for oral appliance therapy. J Orofac Pain 23(4):339–344PubMed

26.

Doff MH, Hoekema A, Pruim GJ, Huddleston Slater JJ, Stegenga B (2010) Long-term oral-appliance therapy in obstructive sleep apnea: a cephalometric study of craniofacial changes. J Dent 38(12):1010–1018PubMedCrossRef

27.

Giannasi LC, Almeida FR, Magini M, Costa MS, de Oliveira CS, de Oliveira JC, Kalil Bussadori S, de Oliveira LV (2009) Systematic assessment of the impact of oral appliance therapy on the temporomandibular joint during treatment of obstructive sleep apnea: long-term evaluation. Sleep Breath 13(4):375–381PubMedCrossRef

28.

Bondemark L, Lindman R (2000) Craniomandibular status and function in patients with habitual snoring and obstructive sleep apnoea after nocturnal treatment with a mandibular advancement splint: a 2-year follow-up. Eur J Orthod 22(1):53–60PubMedCrossRef

29.

Martinez-Gomis J, Willaert E, Nogues L, Pascual M, Somoza M, Monasterio C (2010) Five years of sleep apnea treatment with a mandibular advancement device. Side effects and technical complications. Angle Orthod 80(1):30–36PubMedCrossRef

30.

Fransson AM, Tegelberg A, Johansson A, Wenneberg B (2004) Influence on the masticatory system in treatment of obstructive sleep apnea and snoring with a mandibular protruding device: a 2-year follow-up. Am J Orthod Dentofacial Orthop 126(6):687–693PubMedCrossRef

31.

de Almeida FR, Bittencourt LR, de Almeida CI, Tsuiki S, Lowe AA, Tufik S (2002) Effects of mandibular posture on obstructive sleep apnea severity and the temporomandibular joint in patients fitted with an oral appliance. Sleep 25(5):507–513PubMed

32.

Chen H, Lowe AA, de Almeida FR, Fleetham JA, Wang B (2008) Three-dimensional computer-assisted study model analysis of long-term oral-appliance wear. Part 2. Side effects of oral appliances in obstructive sleep apnea patients. Am J Orthod Dentofacial Orthop 134(3):408–417PubMedCrossRef

33.

Fritsch KM, Iseli A, Russi EW, Bloch KE (2001) Side effects of mandibular advancement devices for sleep apnea treatment. Am J Respir Crit Care Med 164(5):813–818PubMed

34.

Ghazal A, Jonas IE, Rose EC (2008) Dental side effects of mandibular advancement appliances—a 2-year follow-up. J Orofac Orthop 69(6):437–447PubMedCrossRef

35.

Marklund M, Franklin KA, Persson M (2001) Orthodontic side-effects of mandibular advancement devices during treatment of snoring and sleep apnoea. Eur J Orthod 23(2):135–144PubMedCrossRef

36.

Pantin CC, Hillman DR, Tennant M (1999) Dental side effects of an oral device to treat snoring and obstructive sleep apnea. Sleep 22(2):237–240PubMed

37.

Robertson C, Herbison P, Harkness M (2003) Dental and occlusal changes during mandibular advancement splint therapy in sleep disordered patients. Eur J Orthod 25(4):371–376PubMedCrossRef

38.

Rose EC, Staats R, Virchow C Jr, Jonas IE (2002) Occlusal and skeletal effects of an oral appliance in the treatment of obstructive sleep apnea. Chest 122(3):871–877PubMedCrossRef

39.

Almeida FR, Lowe AA, Otsuka R, Fastlicht S, Farbood M, Tsuiki S (2006) Long-term sequellae of oral appliance therapy in obstructive sleep apnea patients: part 2. Study-model analysis. Am J Orthod Dentofacial Orthop 129(2):205–213PubMedCrossRef

40.

Monteith BD (2004) Altered jaw posture and occlusal disruption patterns following mandibular advancement therapy for sleep apnea: a preliminary study of cephalometric predictors. Int J Prosthodont 17(3):274–280PubMed

41.

Otsuka R, Almeida FR, Lowe AA (2007) The effects of oral appliance therapy on occlusal function in patients with obstructive sleep apnea: a short-term prospective study. Am J Orthod Dentofacial Orthop 131(2):176–183PubMedCrossRef

42.

Ueda H, Almeida FR, Chen H, Lowe AA (2009) Effect of 2 jaw exercises on occlusal function in patients with obstructive sleep apnea during oral appliance therapy: a randomized controlled trial. Am J Orthod Dentofacial Orthop 135 (4):430 e431-437; discussion 430-431

43.

George PT (1992) A new instrument for functional appliance bite registration. J Clin Orthod 26(11):721–723PubMed

44.

Dworkin SF, LeResche L (1992) Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 6(4):301–355PubMed

45.

Doff MH, Veldhuis SK, Hoekema A, Slater JJ, Wijkstra PJ, de Bont LG, Stegenga B (2011) Long-term oral appliance therapy in obstructive sleep apnea syndrome: a controlled study on temporomandibular side effects. Clin Oral Investig. doi:10.1007/s00784-011-0555-6

46.

Marklund M, Stenlund H, Franklin KA (2004) Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Chest 125(4):1270–1278PubMedCrossRef

47.

Al-Ani MZ, Davies SJ, Gray RJ, Sloan P, Glenny AM (2004) Stabilisation splint therapy for temporomandibular pain dysfunction syndrome. Cochrane Database Syst Rev (1):CD002778

48.

Garcia AR, Folli S, Zuim PR, de Sousa V (2008) Mandible protrusion and decrease of TMJ sounds: an electrovibratographic examination. Braz Dent J 19(1):77–82PubMedCrossRef

49.

Kurita H, Ohtsuka A, Kurashina K, Kopp S (2001) A study of factors for successful splint capture of anteriorly displaced temporomandibular joint disc with disc repositioning appliance. J Oral Rehabil 28(7):651–657PubMedCrossRef

50.

Okeson JP (2008) Management of temporomandibular disorders and occlusion. Mosby, St. Louis

51.

Bondemark L (1999) Does 2 years' nocturnal treatment with a mandibular advancement splint in adult patients with snoring and OSAS cause a change in the posture of the mandible? Am J Orthod Dentofacial Orthop 116(6):621–628PubMedCrossRef

52.

McGown AD, Makker HK, Battagel JM, L'Estrange PR, Grant HR, Spiro SG (2001) Long-term use of mandibular advancement splints for snoring and obstructive sleep apnoea: a questionnaire survey. Eur Respir J 17(3):462–466PubMedCrossRef

53.

Levendowski DJ, Morgan TD, Patrickus JE, Westbrook PR, Berka C, Zavora T, Popovic D (2007) In-home evaluation of efficacy and titration of a mandibular advancement device for obstructive sleep apnea. Sleep Breath 11(3):139–147PubMedCrossRef

54.

Westbrook PR, Levendowski DJ, Cvetinovic M, Zavora T, Velimirovic V, Henninger D, Nicholson D (2005) Description and validation of the apnea risk evaluation system: a novel method to diagnose sleep apnea–hypopnea in the home. Chest 128(4):2166–2175PubMedCrossRef

55.

Ayappa I, Norman RG, Seelall V, Rapoport DM (2008) Validation of a self-applied unattended monitor for sleep disordered breathing. J Clin Sleep Med 4(1):26–37PubMed

56.

Chen H, Lowe AA, Bai Y, Hamilton P, Fleetham JA, Almeida FR (2009) Evaluation of a portable recording device (ApneaLink) for case selection of obstructive sleep apnea. Sleep Breath 13(3):213–219PubMedCrossRef

57.

Lettieri CJ, Paolino N, Eliasson AH, Shah AA, Holley AB (2011) Comparison of adjustable and fixed oral appliances for the treatment of obstructive sleep apnea. J Clin Sleep Med 7(5):439–445PubMed

58.

Sari E, Menillo S (2011) Comparison of titratable oral appliance and mandibular advancement splint in the treatment of patients with obstructive sleep apnea. doi:10.5402/2011/581692

59.

Ahrens A, McGrath C, Hagg U (2011) A systematic review of the efficacy of oral appliance design in the management of obstructive sleep apnoea. Eur J Orthod. 33(3):318–324

60.

Mehta A, Qian J, Petocz P, Darendeliler MA, Cistulli PA (2001) A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med 163(6):1457–1461

Title: The incidence and prevalence of temporomandibular disorders and posterior open bite in patients receiving mandibular advancement device therapy for obstructive sleep apnea
Authors: Cristina V. Perez
Reny de Leeuw
Jeffrey P. Okeson
Charles R. Carlson
Hsin-Fang Li
Heather M. Bush
Donald A. Falace
Publication date: 01-03-2013
Publisher: Springer-Verlag
Published in: Sleep and Breathing / Issue 1/2013
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-012-0695-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2013

Comparison of three actigraphic algorithms used to evaluate sleep in patients with obstructive sleep apnea

Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis

Validation of ApneaLink Ox™ for the diagnosis of obstructive sleep apnea

Assessment of the impact on compliance of a new CPAP system in obstructive sleep apnea

Short-term severe thyroid hormone deficiency does not influence sleep parameters

Relationship of obstructive sleep apnea syndrome with the 5-HT2A receptor gene in Brazilian patients

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials